Matrivax Overview

  • Founded
  • 2007
  • Status
  • Private
  • Employees
  • 23
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $321K
Latest Deal Amount
  • Investors
  • 3

Matrivax General Information


Operator of a biotechnology company intended to develop vaccines to treat infectious bacteria including Streptococcus pneumonia. The company's vaccines use the protein capsular matrix vaccine (PCMV) technology platform to produce polysaccharide-based vaccines for diseases such as pneumococcal infections, enteric fever and meningococcal disease, enabling patients to get cure from enteric fever and meningococcal diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 650 Albany Street
  • Suite 117
  • Boston, MA 02118
  • United States
+1 (617) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Matrivax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 18-Mar-2010 $321K Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 10-Oct-2007 Completed Startup
To view Matrivax’s complete valuation and funding history, request access »

Matrivax Executive Team (9)

Name Title Board Seat Contact Info
Edward Mascioli MD Chief Executive Officer, President and Board Member
Jeffery Brinza JD Chief Legal Officer
Kevin Killeen Ph.D Chief Scientific Officer
Thomas Griffin Ph.D Director, Research
Leisa Dennehy Chief Corporate Development Officer
You’re viewing 5 of 9 executive team members. Get the full list »

Matrivax Board Members (4)

Name Representing Role Since
Edward Mascioli MD Matrivax Chief Executive Officer, President and Board Member 000 0000
Gerald Chan Ph.D Morningside Group Board Member 000 0000
John Mekalanos Ph.D Matrivax Board Member and Co-Founder 000 0000
Yichen Lu Ph.D Matrivax Co-Founder and Board Member 000 0000
To view Matrivax’s complete board members history, request access »

Matrivax Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Matrivax Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital 000 0000 000000 0
Massachusetts Life Sciences Center Government 000 0000 000000 0
Morningside Group Venture Capital Minority 000 0000 000000 0
To view Matrivax’s complete investors history, request access »